Ipamorelin vs Sermorelin
Updated 11 sources
Key differences
- 1Sermorelin is GHRH(1-29) and was once an FDA-approved drug (Geref) with pediatric data. Ipamorelin is a GHRP that was never approved.
- 2Ipamorelin's half-life is about 2 hours after IV dosing; sermorelin's is measured in minutes.
- 3Sermorelin acts on the GHRH receptor; ipamorelin on the ghrelin receptor. They are usually stacked.
- 4Sermorelin was FDA approved and has pediatric data. Ipamorelin was never approved, and its half-life is about 2 hours after IV dosing.
Side by side
Facts from each record, in the same words as their own pages.
| Ipamorelin | Sermorelin | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
11 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study4
- Ipamorelin PK-PD (Gobburu 1999)PubMed · checked Oct 23, 2026
- Sermorelin review (Prakash & Goa 1999)PubMed · checked Oct 23, 2026
- hGRF1-29NH2 plasma levels after IV and SC (Rafferty 1985)PubMed · checked Oct 23, 2026
- Performance-enhancing peptides modulating GH-IGF1 axis (Dominikowski 2026)PMC · checked Oct 23, 2026
Regulatory4
- Certain bulk drug substances, safety risksFDA · checked Oct 23, 2026
- 503A bulk drug substance categories (May 14, 2026)FDA · checked Oct 23, 2026
- Drugs@FDA Geref records (openFDA)FDA · checked Oct 23, 2026
- Determination that Geref was not withdrawn for safety or effectivenessFederal Register · checked Oct 24, 2026
Competitor guide3
- SermorelinPeptidesExplorer · checked Oct 23, 2026
- Sermorelin dosage guideBodyHackGuide · checked Oct 23, 2026
- Sermorelin dosage guidePeptideDeck · checked Oct 23, 2026